UPDATE 1-U.S. FDA approves Merck's new hepatitis C pill
January 28, 2016 at 19:48 PM EST
Jan 28 (Reuters) - U.S. regulators on Thursday approved a new once-daily pill for the liver-destroying hepatitis C virus made by Merck & Co Inc, which said it will sell the drug at a lower list price than its competitors.
